Percutaneous, laparoscopic and open surgical radiofrequency ablation of malignant liver lesions;Interventionelle, Laparoskopische und Offen Operative Radiofrequenztherapie Maligner Leberläsionen

Zentralblatt fur Chirurgie

Volumn 132, Issue 4, 2007, Pages 293-299

  Stippel, D L ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Klinik und Poliklinik fur Frauenheilkunde und Geburtshilfe   (Germany)

Author keywords

Approach; Liver metastasis; Outcome; Primary liver cancer; RFA

Indexed keywords

ARTICLE; CATHETER ABLATION; COLORECTAL TUMOR; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FOLLOW UP; LAPAROSCOPY; LIVER; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER TUMOR; META ANALYSIS; METASTASIS; METHODOLOGY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; FOLLOW-UP STUDIES; LAPAROSCOPY; LIVER; LIVER ABSCESS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; META-ANALYSIS AS TOPIC; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548393540     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981198     Document Type: Article

References (47)

1. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825
2. Ahmed M, Liu Z, Afzal KS, Weeks D, Lobo SM, Kruskal JB, Lenkinski RE, Goldberg SN. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 2004; 230: 761-767
3. Bangard C, Gossmann A, Kasper HU, Hellmich M, Fischer JH, Holscher AH, Lackner K, Stippel DL. Experimental radiofrequency ablation near the portal and the hepatic veins in pigs: differences in efficacy of a monopolar ablation system. J Surg Res 2006; (im Druck)
4. Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005; 23: 1358-1364
5. Cervone A, Sardi A, Conaway GL. Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg 2000; 66: 611-615
6. Chang CK, Hendy MP, Smith JM, Recht MH, Welling RE. Radiofrequency ablation of the porcine liver with complete hepatic vascular occlusion. Ann Surg Oncol 2002; 9: 594-598
7. Elias D, Baton O, Sideris L, Boige V, Malka D, Liberale G, Pocard M, Lasser P. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol 2005; 90: 36-42
8. Elias D, Sideris L, Pocard M, de Baere T, Dromain C, Lassau N, Lasser P, Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation). Ann Surg Oncol 2005; 12: 298-302
9. Elias D, Sideris L, Pocard M, Dromain C, De Baere T. Intraductal cooling of the main bile ducts during radiofrequency ablation prevents biliary stenosis. J Am Coll Surg 2004; 198: 717-721
10. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318
11. Germer CT, Buhr HJ, Isbert C. Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment. Chirurg 2005; 76: 552-563
12. Gillams AR. The use of radiofrequency in cancer. Br J Cancer 2005; 92: 1825-1829
13. Gillams AR, Lees WR. Radiofrequency ablation of colorectal liver metastases. Abdom Imaging 2005; 30: 419-426
14. Goldberg SN. Science to practice: can we differenziate residual untreated tumor from tissue responses to heat following thermal tumor ablation? Radiology 2005; 234: 317-318
15. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol 1995; 2: 670-674
16. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1995; 2: 399-404
17. Goldberg SN, Gazelle GS, Halpern EF, Rittman WJ, Mueller PR, Rosenthal DI. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996; 3: 212-218
18. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD, Dupuy DE, Gervais D, Gillams AR, Kane RA, Lee FT, Livraghi T, McGahan J, Phillips DA, Rhim H, Silverman SG. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235: 728-739
19. Hansen PD, Rogers S, Corless CL, Swanstrom LL, Siperstien AE. Radiofrequency ablation lesions in a pig liver model. J Surg Res 1999; 87: 114-121
20. Investigators C. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology 2000; 31: 840-845
21. Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 2005; 31: 331-347
22. Karmali S, Dixon E. Biliary stricture resulting from radiofrequency ablation. Am J Surg 2004; 188: 76-77
23. Kim SH, Lim HK, Choi D, Lee WJ, Kim MJ, Lee SJ, Lim JH. Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance. AJR Am J Roentgenol 2004; 183: 1611-1617
24. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240
25. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54:1151-1156
26. Lu DS, Yu NC, Raman SS, Limanond P, Lassman C, Murray K, Tong MJ, Amado RG, Busuttil RW. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005; 234: 954-960
27. Marchai F, Elias D, Rauch P, Zarnegar R, Leroux A, Stines J, Verhaeghe JL, Guillemin F, Carteaux JP, Villemot JP. Prevention of biliary lesions that may occur during radiofrequency ablation of the liver: study on the pig. Ann Surg 2006: 243: 82-88
28. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, Sarli D, Schiavo M, Garbagnati F, Marchiano A, Spreafico C, Camerini T, Mariani L, Miceli R, Andreola S. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004; 240: 900-909
29. Montgomery RS, Rahal A, Dodd GD, Leyendecker JR, Hubbard LG. Radiofrequency ablation of hepatic tumors: variability of lesion size using a single ablation device. AJR Am J Roentgenol 2004; 182: 657-661
30. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I, Michel L. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002; 89: 1206-1222
31. Mulier S, Ni Y, Jamart J, Ruers T, Marchai G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242: 158-171
32. Mulier S, Ni Y, Miao Y, Rosiere A, Khoury A, Marchai G, Michel L. Size and geometry of hepatic radiofrequency lesions. Eur J Surg Oncol 2003; 29: 867-878
33. Ng KK, Lam CM, Poon RT, Shek TW, Fan ST, Wong J. Delayed portal vein thrombosis after experimental radiofrequency ablation near the main portal vein. Br J Surg 2004; 91: 632-639
34. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227: 559-565
35. Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003; 10: 1059-1069
36. Pereira PL, Trubenbach J, Schenk M, Subke J, Kroeber S, Schaefer I, Remy CT, Schmidt D, Brieger J, Claussen CD. Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology 2004; 232: 482-490
37. Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 2005; 11: 1117-1126
38. Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST, Wong J. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 2004; 239: 441-449
39. Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging 2005; 30: 409-418
40. Santambrogio R, Podda M, Zuin M, Bertolini E, Bruno S, Cornalba GP, Costa M, Montorsi M. Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis. Surg Endose 2003; 17: 1826-1832
41. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130
42. Siperstein A, Garland A, Engle K, Rogers S, Berber E, String A, Foroutani A, Ryan T. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations. Surg Endosc 2000; 14: 400-405
43. Solazzo SA, Liu Z, Lobo SM, Ahmed M, Hines-Peralta AU, Lenkinski RE, Goldberg SN. Radiofrequency ablation: importance of background tissue electrical conductivity - an agar phantom and computer modeling study. Radiology 2005; 236: 495-502
44. Stippel DL, Bangard C, Kasper HU, Fischer JH, Holscher AH, Gossmann A. Experimental bile duct protection by intraductal cooling during radiofrequency ablation. Br J Surg 2005; 92: 849-855
45. Stippel DL, Brochhagen HG, Arenja M, Hunkemoller J, Holscher AH, Beckurts KT. Variability of size and shape of necrosis induced by radiofrequency ablation in human livers: a volumetric evaluation. Ann Surg Oncol 2004; 11: 420-425
46. Stippel DL, Tox U, Gossmann A, Beckurts KT, Holscher AH. Successful treatment of radiofrequency-induced biliary lesions by interventional endoscopic retrograde cholangiography (ERC). Surg Endosc 2003; 17: 1965-1970
47. Wiersinga WJ, Jansen MC, Straatsburg IH, Davids PH, Klaase JM, Gouma DJ, Van Gulik TM. Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver. Br J Surg 2003; 90: 306-312